Variations in the management of canine osteoarthritis: a cross-sectional survey of veterinary practices.

Introduction: There is limited data on how veterinarians implement multimodal therapies for managing canine osteoarthritis (OA). The primary aim of this study was to describe how OA is managed by veterinarians with diverse backgrounds. The secondary aim was to report perceived side effects associated with bedinvetmab (Librela Methods: A cross-sectional, observational, voluntary response survey was distributed to veterinarians assessing respondent demographics, diagnostic approaches, the frequency of treatment use for canine OA, and perceived adverse events associated with grapiprant and bedinvetmab. Results: 373 responses were analyzed. Non-steroidal anti-inflammatory drugs (NSAIDs) were the most prescribed drug class, and gabapentin, bedinvetmab, and polysulfated glycosaminoglycan (Adequan Conclusion: There is variation in multimodal approaches to canine OA management influenced by both training and years of clinical experience. While NSAIDs, omega-3 fatty acids, and weight management remain foundational, this study demonstrates a spectrum of utilized adjunctive strategies. The differences highlight opportunities for further research into the safety and efficacy of commonly used therapies. Reported perceived adverse events associated with bedinvetmab and grapiprant underscore the need for pharmacovigilance and further research investigating safety.